Nageswaran Sivalingam
7PUBLICATIONS
0CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 16, 2026
Secretion of IL-6 and TGF-β2 by Colon Cancer Cells May Promote Resistance to Chemotherapy.Sruthi Sritharan, Nageswaran Sivalingam
|Jul 02, 2025
A recent decade update on combating doxorubicin-induced toxicities.Sruthi Sritharan, Nageswaran Sivalingam
|Feb 03, 2024
Doxorubicin-induced chemoresistance in Duke's type B colon adenocarcinoma cell line is aggravated in the presence of TGF-β2 through non-apoptotic cell death.Sruthi Sritharan, Nageswaran Sivalingam
|Jun 18, 2022
Meta analysis of bioactive compounds, miRNA, siRNA and cell death regulators as sensitizers to doxorubicin induced chemoresistance.Sruthi Sritharan, Sampurna Guha, Snoopy Hazarika
|Oct 07, 2020
Curcumin induces chemosensitization to doxorubicin in Duke's type B coloadenocarcinoma cell line.Jeyan Jayarajan, Sruthy Angandoor, Sri Harsha Vedulla
|Sep 01, 2020
Curcumin induced apoptosis is mediated through oxidative stress in mutated p53 and wild type p53 colon adenocarcinoma cell lines.Sruthi Sritharan, Nageswaran Sivalingam
Pageof 2
